School of Medicine

Showing 1-10 of 37 Results

• 

  Aya Kamaya, MD

  Associate Professor of Radiology (Body Imaging) at the Stanford University Medical Center

  Current Research and Scholarly Interests Hepatobiliary imaging
  Hepatocellular carcinoma
  Urologic imaging
  Gynecologic imaging
  Thyroid imaging
  Novel ultrasound technologies
  Perfusion CT imaging of abdominal tumors

• 

  Michael J. Kaplan

  Professor of Otolaryngology - Head and Neck Surgery at the Stanford University Medical Center, Emeritus

  Current Research and Scholarly Interests 1) New therapeutic approaches for head and neck cancer, including immune stimulation possibilities (IRX-2 protocol), integration of biological modifiers, and, eventually, genetic approaches.
  2) Head and neck cancer stem cells: identification, characterization, control--in conjunction with the Irv Weissman and Michael Clarke labs in the Stem Cell Institute
  3) Development of innovative surgical methods at the anterior cranial base

• 

  Daniel Kapp

  Professor of Radiation Oncology, Emeritus

  Current Research and Scholarly Interests Gynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.

• Kremena Karagyozova

  Life Science Research Professional 1, Stanford Cancer Institute

• 

  Amer Karam

  Clinical Associate Professor, Obstetrics & Gynecology - Gynecologic Oncology

  Bio Dr. Amer Karam attended medical school at the American University in Beirut. He completed his internship and residency at the Johns Hopkins Hospital in Baltimore, Maryland, a fellowship in gynecologic oncology at the University of California Los Angeles and a fellowship in breast surgery at the Memorial Sloan-Kettering Cancer Center. Dr. Karam has a vested interest in minimally invasive and robotic surgery with a practice centered on this approach for the treatment of patients with gynecologic malignancy and complicated pelvic surgery. He is currently an associate clinical professor at the Stanford Hospital and Clinics and Director of Robotic Surgery and Outreach in the Division of Gynecologic Oncology

• Daiki Karigane

  Postdoctoral Research Fellow, Stanford Cancer Center

• Kasper Karlsson

  Postdoctoral Research Fellow, Stanford Cancer Center

• 

  Laurence Katznelson, MD

  Professor of Neurosurgery and of Medicine (Endocrinology) at the Stanford University Medical Center, Lucile Salter Packard Children's Hospital and at the Palo Alto Veterans Affairs Health Care System

  Current Research and Scholarly Interests Dr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushing’s syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education

• 

  Mark A. Kay, M.D., Ph.D.

  Dennis Farrey Family Professor in Pediatrics, and Professor of Genetics

  Current Research and Scholarly Interests Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.

• 

  Electron Kebebew, MD, FACS

  Harry A. Oberhelman, Jr. and Mark L. Welton Professor

  Current Research and Scholarly Interests Dr. Kebebew?s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.